PMS30 Cost-Effectiveness of Tocilizumab Compared to Standard Therapeutic Sequences for the Treatment of Moderate/Severe Rheumatoid Arthritis (RA) Patients in Portugal
Abstract
Authors
A. Diamantopoulos S. Andrade A. Bernardo J. Branco L. Inês J.A. Pereira da Silva M.J. Santos I. Monteiro